Company intelligence / Profile preview

Celgenic Labs

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Celgenic is a biotechnology and health sciences company focused on developing advanced longevity and wellness solutions. The company specializes in the formulation of high-purity supplements and therapeutic compounds designed to optimize cellular health and metabolic function. Their product portfolio often emphasizes NAD+ precursors and other longevity-focused molecules aimed at slowing the biological aging process. Celgenic operates primarily in the consumer health and wellness space, bridging the gap between clinical research and accessible health optimization products.

Therapeutic areas: NeurologyOtherMetabolic Disorders
Modalities: Small moleculePeptidesNutraceuticals
Industry: Food & Nutrition

Beyond the preview

Go deeper on Celgenic Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celgenic Labs.

Explore the full profile